Circulating VE-cadherin in patients with controlled chronic lymphocytic leukemia

Circulating VE-cadherin in patients with controlled chronic lymphocytic leukemia

Aim. To evaluate the prognostic value of circulating VE-cadherin for cumulative survival in asymptomatic coronary artery disease patients with full or partial remission of limphoproliferative diseases. Methods. One hundred twelve patients with full or partial remission of chronic lymphocytic leuk...

Full description

Bibliographic Details
Main Author:	10.14739/2310-1237.2014.2.28551
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2014-08-01
Series:	Patologìâ
Subjects:	VE-cadherin Chronic Lymphocytic Leukemia Survival Prognosis
Online Access:	http://pat.zsmu.edu.ua/article/view/28551/25530

Similar Items

NEW INSIGHTS ON THE ROLE OF VE-CADHERIN IN RHEUMATOID ARTHRITIS
by: A.I. Costea, et al.
Published: (2012-03-01)

The Role of Epithelial and Vascular-Endothelial Cadherin in the Differentiation and Maintance of Tissue Integrity
by: Petr Nachtigal, et al.
Published: (2001-01-01)

Turmeric (Curcuma longa) Decoctum Had no Effect on Vascular Endothelial Growth Factor (VEGF) and Vascular Endothelial Cadherin (VE-cadherin) Expression in the Chick Embryo
by: Sri Winarsih, et al.
Published: (2018-09-01)

Value of circulating galectin-3 for prognosis of cardiovascular events in patients with chronic lymphocytic leukemia in remission
by: B. B. Samura, et al.
Published: (2014-12-01)

The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium
by: Thomas Brock, et al.
Published: (2021-06-01)

Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors
by: Mesut Ayer, et al.
Published: (2018-09-01)

Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
by: Celso Arrais Rodrigues, et al.

Prognosis related to staging systems for chronic lymphocytic leukemia
by: José Roberto de Faria, et al.
Published: (2000-07-01)

Mechanisms Ensuring Endothelial Junction Integrity Beyond VE-Cadherin
by: Cao Nguyen Duong, et al.
Published: (2020-05-01)

Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin
by: Pascaline Nguemgo Kouam, et al.
Published: (2019-10-01)

Immunogenetics of chronic lymphocytic leukemia
by: Nikhil Patkar, et al.
Published: (2017-01-01)

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
by: Candida Vitale, et al.
Published: (2021-07-01)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
by: Myung-Giun Noh, et al.
Published: (2017-08-01)

Long-term chronic lymphocytic leukemia survivors’ quality of life
by: B. B. Samura
Published: (2014-10-01)

Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
by: Francesca Romana Mauro, et al.
Published: (2021-06-01)

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
by: Isabel González-Gascón-y-Marín, et al.
Published: (2021-04-01)

Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis
by: J. Ignacio Casal, et al.
Published: (2019-07-01)

Modifications post-traductionnelles de la VE-cadhérine : des mécanismes moléculaires aux applications cliniques
by: Sidibe, Adama
Published: (2012)

Overview of recent developments in chronic lymphocytic leukemia
by: Preetesh Jain, et al.
Published: (2012-01-01)

Endothelial Phosphatase VE-PTP Participates in Vasculogenic Mimicry by Preventing Autophagic Degradation of VE-Cadherin
by: Daniel Delgado-Bellido, et al.
Published: (2020-01-01)

Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS
by: Arianna Piotti, et al.
Published: (2021-03-01)

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia
by: Giovanni D’Arena, et al.
Published: (2021-08-01)

Genistein elicits its anticancer effects through up-regulation of E-Cadherin in Acute Lymphoblastic Leukemia (ALL) cells: an in vitro experimental study
by: Vahideh Namordizadeh, et al.
Published: (2019-03-01)

Implication de la VE-cadhérine dans la plasticité endothéliale des tumeurs
by: Le Guelte, Armelle
Published: (2012)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

Interleukin-8 Secreted by Glioblastoma Cells Induces Microvascular Hyperpermeability Through NO Signaling Involving S-Nitrosylation of VE-Cadherin and p120 in Endothelial Cells
by: Anita Guequén, et al.
Published: (2019-08-01)

PIEZO1 Ion Channel Mediates Ionizing Radiation-Induced Pulmonary Endothelial Cell Ferroptosis via Ca2+/Calpain/VE-Cadherin Signaling
by: Xue-Wei Guo, et al.
Published: (2021-09-01)

CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance
by: Giovanni D’Arena, et al.
Published: (2020-11-01)

“Switch of E-Cadherin to N-Cadherin expression in different molecular subtypes of breast invasive duct carcinomas and its correlation with clinicopathological features”
by: Mayada S Farrag, et al.
Published: (2021-01-01)

The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution
by: Adrián Mosquera Orgueira, et al.
Published: (2019-05-01)

Role Of Adhesion Molecules Vcam-1 And Ve-Cadherin In Endothelium Dysfunction Development At Hemorrhagic Fever With Renal Syndrome
by: А.А. Baygildina
Published: (2009-12-01)

Activated allogeneic NK cells preferentially kill poor prognosis B-cell chronic lymphocytic leukemia cells
by: Diego Sanchez-Martinez, et al.
Published: (2016-10-01)

Chronic lymphocytic leukemia, a rare cause of spontaneous rupture of the spleen
by: Abdelouahab, H., et al.
Published: (2022)

Endothelial Iron Homeostasis Regulates Blood-Brain Barrier Integrity via the HIF2α—Ve-Cadherin Pathway
by: Daniel Rand, et al.
Published: (2021-02-01)

Marcadores de prognóstico na leucemia linfocítica crônica Prognostic factors in chronic lymphocytic leukemia
by: Yuri Vasconcelos
Published: (2005-12-01)

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
by: Xiaoya Yun, et al.
Published: (2020-09-01)

Differential Regulation of LPS-Mediated VE-Cadherin Disruption in Human Endothelial Cells and the Underlying Signaling Pathways: A Mini Review
by: Yee Han Chan, et al.
Published: (2020-01-01)

Phosphorylation sur tyrosine de la VE-cadhérine en réponse au VEGF : mécanismes moléculaires et implications physiopathologiques
by: Wallez, Yann
Published: (2007)

Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia
by: Yi-Xin Zou, et al.
Published: (2021-10-01)

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
by: Claudia Pérez-Carretero, et al.
Published: (2021-05-01)